HHS joins Trump’s drive to use AI to address chronic disease

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warnings
Experts caution the move amounts to a “huge, unregulated, natural experiment”

In a video captioned “The High-T Department of War” and posted on X, Secretary of Defense Pete Hegseth announced that he was authorizing a screening program for troops to ensure “you have the right testosterone levels to operate at your absolute best.”

July 24, 2026

Vol.52 No.29

By Claire Marie Porter

Cancer Policy

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

HHS and the Centers for Medicare & Medicaid Services deferred more than $1 billion in federal Medicaid payments to California and Minnesota as these states submit additional documentation supporting certain Medicaid claims.

White House regulatory priorities include “aggressive” HHS agenda

The White House Office for Regulatory Affairs and Information released a series of documents detailing each agency’s regulatory priorities for the coming year.

HHS cancels fourth USPSTF meeting in a row

A scheduled U.S. Preventive Services Task Force meeting has been canceled, marking the fourth consecutive cancellation by HHS.

July 17, 2026

Vol.52 No.28

By Claire Marie Porter

Podcast

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

In this week’s episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, and Sara Willa Ernst, reporter, break down HHS’ latest vision for the future: Operation Trailblazer.

July 01, 2026

Regulatory News

To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

HHS earlier this week rolled out a cluster of initiatives related to simplifying clinical trials, presenting these measures as a government-wide effort to maintain America’s leadership in early-stage drug development.

June 26, 2026

Vol.52 No.25

By Paul Goldberg

HHS joins Trump’s drive to use AI to address chronic disease

YOU MAY BE INTERESTED IN

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warnings
Experts caution the move amounts to a “huge, unregulated, natural experiment”

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

White House regulatory priorities include “aggressive” HHS agenda

HHS cancels fourth USPSTF meeting in a row

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

Renew today!

Subscriber content

Never miss an issue!

Login

HHS joins Trump’s drive to use AI to address chronic disease

YOU MAY BE INTERESTED IN

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warningsExperts caution the move amounts to a “huge, unregulated, natural experiment”

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

White House regulatory priorities include “aggressive” HHS agenda

HHS cancels fourth USPSTF meeting in a row

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

Never miss an issue!

Login

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warnings
Experts caution the move amounts to a “huge, unregulated, natural experiment”